Investor mix
2 investors on record; lead investors include Idinvest Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Private equity | 1 | 50% |
Antibody-based checkpoint inhibitors for oncology.
2 investors on record; lead investors include Idinvest Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Private equity | 1 | 50% |